Analyst Research: Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Global Select Market

4.27USD
4:00pm EDT
Price Change (% chg)

$0.41 (+10.62%)
Prev Close
$3.86
Open
$3.90
Day's High
$4.50
Day's Low
$3.87
Volume
738,662
Avg. Vol
191,278
52-wk High
$4.73
52-wk Low
$2.61

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - VICAL INCORPORATED (VICL-O) 6:34am EDT Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for VICL 31 Jul 2013 ValuEngine, Inc. 11 25.00
VICAL INC (VICL) - REPORT FOR ACTIVE TRADERS 29 Jul 2013 Pechala's Reports 1 25.00
Vical Inc 27 Jul 2013 S&P Capital IQ Quantitative Report 6 69.00
VICAL INC (VICL) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Vical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 25 Jul 2013 Jefferson Research 11 20.00
VICL: Due Diligence Review: Forensic Earnings and Valuation 23 Jul 2013 New Constructs, LLC 13 25.00
TheStreet.com Ratings Stock Report For: VICAL INC (VICL) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

R. Gordan Douglas

77 1999 Independent Chairman of the Board

Vijay Samant

60 2013 President, Chief Executive Officer, Acting Chief Financial Officer, Director

Alain Rolland

53 2009 Executive Vice President - Product Development

Igor Bilinsky

40 2010 Senior Vice President - Corporate Development

Mammen Mammen

49 2012 Vice President - Clinical Vaccines
Search Stocks